跳至主要内容
临床试验/IRCT2015050322066N1
IRCT2015050322066N1已完成2 期

Randomized control trial on effect of octereotide in control of nonvariceal upper gastrointestinal bleeding

Vice Chancellor of Research, Shiraz University of Medical Sciences0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • inclusion criteria: Conscious patients; age between 18 to 80 years; with complaint of melena or hematemesis or tarry stools in rectal examination
  • Exclusion criteria: patients with congestive heart failure class 4; ESRD patients on hemodialysis; pregnant patients; Patients with acute coronary events; nursing patients; cirrhotic Patients with child score B or C; make any complications of treatment with Octreotide at any time during the study; the patient's willingness to withdraw from the study at any time during the study; taking any anticoagulant; patients suffering from coagulation diseases

排除标准

  • 未提供

研究者

发起方
Vice Chancellor of Research, Shiraz University of Medical Sciences

相似试验